January 9, 2017

Amicus Therapeutics Provides Full-Year 2017 Strategic Outlook and Financial Guidance

January 7, 2017

National Institute for Health and Care Excellence (NICE) Issues Final Positive Recommendation for Galafold™ (migalastat) for Fabry Disease in England

December 23, 2016

Amicus Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference